|
Lorenzo M, Jacobs-Cacha C, Palau P, Amiguet M, Seller J, Nunez E, Espriella R, Gorriz JL, Minana G, Sanchis J, Bayes-Genis A, Soler MJ, Packer M, Nunez J; DAPA-VO2 Investigators. Short-Term Changes in Peak VO2 After Initiation of Dapagliflozin in Heart Failure Across Iron Status. JACC Heart Fail. 2023 Nov;11(11):1611-1622. doi: 10.1016/j.jchf.2023.07.010. Epub 2023 Sep 6. PubMed PMID: 37676213.
AÑO: 2023; IF: 10.3
|
37676213
|
Pascual-Figal D, Lax A, Asensio Lopez MC. Circulating ST2, from biomarker to pathogenic mediator. Rev Esp Cardiol (Engl Ed). 2023 Sep;76(9):672-674. doi: 10.1016/j.rec.2023.02.012. Epub 2023 Apr 19. No abstract available. English, Spanish. PubMed PMID: 37085116.
AÑO: 2023; IF: 5.9
|
|
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabes JA, Sanchez PL, Anguita M, Fernandez-Vazquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Perez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Aguero J, Pocock S, Ottani F, Fuster V, Ibanez B; REBOOT-CNIC investigators. Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT). Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. PubMed PMID: 34351426.
AÑO: 2022; IF: 7.1
|
|
Rao SV, Kirsch B, Bhatt DL, Budaj A, Coppolecchia R, Eikelboom J, James SK, Jones WS, Merkely B, Keller L, Hermanides RS, Campo G, Ferreiro JL, Shibasaki T, Mundl H, Alexander JH; PACIFIC AMI Investigators. A Multicenter, Phase 2, Randomized, Placebo-Controlled, Double-Blind, Parallel-Group, Dose-Finding Trial of the Oral Factor XIa Inhibitor Asundexian to Prevent Adverse Cardiovascular Outcomes After Acute Myocardial Infarction. Circulation. 2022 Oct 18;146(16):1196-1206. doi: 10.1161/CIRCULATIONAHA.122.061612. Epub 2022 Aug 27. Erratum In: Circulation. 2022 Dec 6;146(23):e330. PubMed PMID: 36030390.
AÑO: 2022; IF: 37.8
|
|
Caravaca Perez P, Gonzalez-Juanatey JR, Nuche J, Matute-Blanco L, Serrano I, Martinez Selles M, Vazquez Garcia R, Martinez Dolz L, Gomez-Bueno M, Pascual Figal D, Crespo-Leiro MG, Garcia-Osuna A, Ordonez-Llanos J, Cinca Cuscullola J, Guerra JM, Delgado JF. Renal Function Impact in the Prognostic Value of Galectin-3 in Acute Heart Failure. Front Cardiovasc Med. 2022 Apr 7;9:861651. doi: 10.3389/fcvm.2022.861651. eCollection 2022. PubMed PMID: 35463785; PubMed Central PMCID: PMC9021836.
AÑO: 2022; IF: 3.6
|